4-(2-Phenylquinazolin-4-yl)morpholine
CAS : 307544-21-4
Ref. 3D-HMA54421
| 1g | Arrêté | ||
| 5g | Arrêté | ||
| 10g | Arrêté | ||
| 250mg | Arrêté | ||
| 500mg | Arrêté |
Informations sur le produit
Nom :
4-(2-Phenylquinazolin-4-yl)morpholine
Description :
4-(2-Phenylquinazolin-4-yl)morpholine (4PTQM) is a human liver cancer drug candidate that has potent cytotoxic properties. 4PTQM has been shown to inhibit the phosphoinositide 3-kinase (PI3K) enzyme, which is involved in tumor cell proliferation, migration and survival. It also inhibits the growth of cervical cancer cells in vitro. 4PTQM binds to the pharmacophore of PI3K, which contains a hydrophobic region and several hydrogen bond acceptors. This binding prevents the enzyme from binding its substrate phosphatidylinositol bisphosphate (PIP2), inhibiting its activity. 4PTQM also has been shown to have high cytotoxicity against diploid cells and statistically optimized for potency against cervical cancer cells in vitro.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
291.3 g/mol
Formule :
C18H17N3O
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
